← Leaderboards
May Daher
University Of Tx Md Anderson Can Ctr
$980,227
Attributed
$2,940,682
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2023–25$2.5M$1.9M$1.3M$625K$0
'23
'24
'25
Funding mix
By agency
NIH$2,940,682 · 2
By mechanism
R01$2,940,682 · 2
Top collaborators
- Rafet Basar4 shared
- Katy Rezvani4 shared
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Katy Rezvani$10,195,970
- Rafet Basar$1,227,277
- Indreshpal Kaur$1,947,447
- Dapeng Zhou$1,875,527
- Juan Fueyo$8,546,462
Others in their field
Other Rising Stars on “Exhaustion”
- Richard Pendleton · Leidos Biomedical Research, Inc.$11,154,254
- Andras A. Heczey · Baylor College Of Medicine$2,725,684
- Debattama Rai Sen · Massachusetts General Hospital$2,502,000
- Nana Kwaku Minkah · Seattle Children'S Hospital$2,456,734
- Arta Monir Monjazeb · University Of California At Davis$2,398,453
- Ming Yang · Mucommune, Llc$2,178,184
Research focus
ExhaustionGraft Vs Host DiseaseDesignEventAllogenicFirst-In-HumanClinicCryopreservationDoseEngineered Nk CellB Lymphoid MalignancyAutologousBiobankClinical ProtocolsAntigensCasp9 GeneAdoptive TransferCostAntigen TargetingChimeric Antigen Receptor T CellsCellsCell TherapyCellular TransductionImproved Outcome
Grant awards (4)
Advancing next-generation CAR-NK therapies targeting CD5 positive T cell malignancies to the clinic$1,847,485
R01 · FY2025 · CA
Next Generation Engineered NK Cells for Lymphoma Patients after CD19 CAR-T Cell Failure.$370,575
R01 · FY2025 · CA · contact PI
Next Generation Engineered NK Cells for Lymphoma Patients after CD19 CAR-T Cell Failure.$352,047
R01 · FY2024 · CA · contact PI
Next Generation Engineered NK Cells for Lymphoma Patients after CD19 CAR-T Cell Failure.$370,575
R01 · FY2023 · CA · contact PI